Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder

L. A. Mandos, K. Rickels, N. Cutler, J. Roeschen, J. M. Keppel Hesselink, E. Schweizer
  • International Clinical Psychopharmacology, November 1995, Wolters Kluwer Health
  • DOI: 10.1097/00004850-199511000-00007

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: jan keppel hesselink